JP2023518948A5 - - Google Patents
Info
- Publication number
- JP2023518948A5 JP2023518948A5 JP2022556088A JP2022556088A JP2023518948A5 JP 2023518948 A5 JP2023518948 A5 JP 2023518948A5 JP 2022556088 A JP2022556088 A JP 2022556088A JP 2022556088 A JP2022556088 A JP 2022556088A JP 2023518948 A5 JP2023518948 A5 JP 2023518948A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- imidazole
- sulfonyl
- butyl
- carbamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE2050301-7 | 2020-03-19 | ||
| SE2050301 | 2020-03-19 | ||
| SE2050782 | 2020-06-29 | ||
| SE2050782-8 | 2020-06-29 | ||
| PCT/GB2021/050680 WO2021186185A1 (en) | 2020-03-19 | 2021-03-18 | Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition associated with angiotensin ii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518948A JP2023518948A (ja) | 2023-05-09 |
| JP2023518948A5 true JP2023518948A5 (enExample) | 2024-03-28 |
Family
ID=75339995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556088A Pending JP2023518948A (ja) | 2020-03-19 | 2021-03-18 | アンギオテンシンｉｉに関連する疾患、障害又は状態の治療及び／又は予防に有用な新規化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230159467A1 (enExample) |
| EP (1) | EP4121165A1 (enExample) |
| JP (1) | JP2023518948A (enExample) |
| KR (1) | KR20230004501A (enExample) |
| CN (1) | CN115605265B (enExample) |
| AU (1) | AU2021238939A1 (enExample) |
| BR (1) | BR112022018549A2 (enExample) |
| CA (1) | CA3175559A1 (enExample) |
| CL (1) | CL2022002540A1 (enExample) |
| CO (1) | CO2022014673A2 (enExample) |
| IL (1) | IL296247A (enExample) |
| MX (1) | MX2022011613A (enExample) |
| PH (1) | PH12022552413A1 (enExample) |
| WO (1) | WO2021186185A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202113583D0 (en) * | 2021-09-23 | 2021-11-10 | Vicore Pharma Ab | New compounds |
| CA3212900A1 (en) * | 2021-03-23 | 2022-09-29 | Tomas Fex | Selective angiotensin ii receptor ligands |
| GB202104033D0 (en) * | 2021-03-23 | 2021-05-05 | Vicore Pharma Ab | New compounds |
| KR20240035402A (ko) | 2021-07-09 | 2024-03-15 | 바이코어 파마 아베 | 신규의 선택적 안지오텐신 ii 화합물 |
| JP2024178482A (ja) * | 2021-11-15 | 2024-12-25 | 株式会社アークメディスン | 化合物、アンジオテンシンｉｉタイプ１受容体拮抗剤及び医薬組成物 |
| IE20230600A3 (en) | 2022-12-22 | 2025-09-24 | Vicore Pharma Ab | A method of treating a patient diagnosed with an interstitial lung disease |
| EP4648850A1 (en) * | 2023-01-09 | 2025-11-19 | Vicore Pharma AB | Selective angiotensin ii compounds |
| AU2024331772A1 (en) * | 2023-08-25 | 2026-04-02 | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Thienylsulfonyl carbamates as at2r agonists |
| CN120247885A (zh) * | 2024-01-03 | 2025-07-04 | 武汉人福创新药物研发中心有限公司 | 一种并环类化合物作为at2r激动剂 |
| WO2025252142A1 (zh) * | 2024-06-07 | 2025-12-11 | 江苏柯菲平医药股份有限公司 | 一种血管紧张素ii型2受体激动剂及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5198438A (en) * | 1991-05-07 | 1993-03-30 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
| SE9800550D0 (sv) | 1998-02-24 | 1998-02-24 | A & Science Invest Ab | A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof |
| JP4707321B2 (ja) * | 2001-05-31 | 2011-06-22 | ヴィコール・ファルマ・アーベー | アンギオテンシンｉｉアゴニストとして有用な三環式化合物 |
| CN1529697B (zh) | 2001-05-31 | 2010-09-22 | 维科尔药物公司 | 用作血管紧张素ⅱ激动剂的三环化合物 |
| AU2003302106A1 (en) | 2002-11-21 | 2004-06-15 | Vicore Pharma Ab | New tricyclic angiotensin ii agonists |
| DK1869023T3 (da) * | 2005-04-12 | 2012-04-10 | Vicore Pharma Ab | Nye tricykliske angiotensin-II-agonister |
| US8835471B2 (en) | 2010-06-11 | 2014-09-16 | Vicore Pharma Ab | Use of angiotensin II agonists |
| DE102012004589A1 (de) | 2012-03-09 | 2013-09-12 | Forschungszentrum Jülich GmbH | Agonisten des Angiotensin II AT2-Rezeptors zur Behandlung neurodegenerativer Erkrankungen |
| BR112017012337A2 (pt) | 2014-12-12 | 2018-02-27 | Vicore Pharma Ab | Método para tratamento de doença falciforme, agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró- fármaco do mesmo, uso de um agonista do receptor at2, ou um sal farmaceuticamente aceitável, solvato ou pró-fármaco do mesmo, formulação farmacêutica, e, produto de combinação. |
| WO2016107879A2 (en) | 2014-12-30 | 2016-07-07 | Vicore Pharma Ab | New use of angiotensin ii receptor agonists |
| EP3265082A1 (en) * | 2015-03-02 | 2018-01-10 | Vicore Pharma AB | Angiotensin ii receptor agonist for treating pulmonary fibrosis |
| WO2017221012A1 (en) | 2016-06-21 | 2017-12-28 | Vicore Pharma Ab | Methods and compositions for preventing or reducing the risk of cancer treatment-related cardiotoxicity |
| GB201710906D0 (en) | 2017-07-06 | 2017-08-23 | Vicore Pharma Ab | Compounds and methods for treating peripheral neuropathy |
-
2021
- 2021-03-18 CN CN202180033927.3A patent/CN115605265B/zh active Active
- 2021-03-18 IL IL296247A patent/IL296247A/en unknown
- 2021-03-18 US US17/912,284 patent/US20230159467A1/en active Pending
- 2021-03-18 CA CA3175559A patent/CA3175559A1/en active Pending
- 2021-03-18 EP EP21715951.6A patent/EP4121165A1/en active Pending
- 2021-03-18 WO PCT/GB2021/050680 patent/WO2021186185A1/en not_active Ceased
- 2021-03-18 MX MX2022011613A patent/MX2022011613A/es unknown
- 2021-03-18 KR KR1020227036148A patent/KR20230004501A/ko active Pending
- 2021-03-18 JP JP2022556088A patent/JP2023518948A/ja active Pending
- 2021-03-18 PH PH1/2022/552413A patent/PH12022552413A1/en unknown
- 2021-03-18 AU AU2021238939A patent/AU2021238939A1/en not_active Withdrawn
- 2021-03-18 BR BR112022018549A patent/BR112022018549A2/pt unknown
-
2022
- 2022-09-16 CL CL2022002540A patent/CL2022002540A1/es unknown
- 2022-10-18 CO CONC2022/0014673A patent/CO2022014673A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518948A5 (enExample) | ||
| JP4650412B2 (ja) | チアゾール誘導体およびｖａｐ−１阻害剤としてのその使用 | |
| AU2018202865B2 (en) | Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B | |
| JP2023518474A5 (enExample) | ||
| US20080119462A1 (en) | Method for treating vascular hyperpermeable disease | |
| US20090069288A1 (en) | Novel therapeutic compounds | |
| JP4978464B2 (ja) | Ｖａｐ−１阻害剤活性を有するチアゾール誘導体 | |
| JP2019505541A5 (enExample) | ||
| JP2017526711A5 (enExample) | ||
| JP2022519131A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2023504415A5 (enExample) | ||
| JP2014500322A5 (enExample) | ||
| JP2017538697A5 (enExample) | ||
| JP2019532054A5 (enExample) | ||
| JP2008508188A5 (enExample) | ||
| JP2019532052A5 (enExample) | ||
| JP2012501334A5 (enExample) | ||
| JP2025512995A (ja) | カンナビノイド受容体１アンタゴニスト／インバースアゴニスト及びその使用 | |
| JP2023539614A5 (enExample) | ||
| JP2004532276A5 (enExample) | ||
| JP2009501745A5 (enExample) | ||
| JP2018516873A5 (enExample) | ||
| JP2006528199A5 (enExample) | ||
| JP2021510168A5 (enExample) |